For the fiscal year ending March 2026, revenue was \u00a5351,363 million (YoY +23.3%), operating income was \u00a573,547 million (YoY +16.8%), and net income attributable to owners of the parent was \u00a549,100 million (YoY +21.3%), achieving both revenue and profit growth.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2413","jir_company_name":"M3, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-05-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/2413-20260501-01.pdf","jir_short_summary":"For the fiscal year ending March 2026, revenue was \u00a5351,363 million (YoY +23.3%), operating income was \u00a573,547 million (YoY +16.8%), and net income attributable to owners of the parent was \u00a549,100 million (YoY +21.3%), achieving both revenue and profit growth.","jir_summary":"### Performance Overview\nIn the fiscal year ending March 2026, M3, Inc. achieved revenue of \u00a5351,363 million (YoY +23.3%), operating income of \u00a573,547 million (YoY +16.8%), profit before tax of \u00a576,276 million (YoY +17.7%), net income of \u00a554,046 million (YoY +21.9%), and net income attributable to owners of the parent of \u00a549,100 million (YoY +21.3%), marking revenue and profit growth. By segment, Medical Platform, Patient Solutions, and Site Solutions performed strongly, with Patient Solutions revenue increasing by 159.5% due to effects from new consolidation. Cash flow from operating activities also increased to \u00a570,262 million, strengthening the financial base.\n\n### Outlook and Shareholder Returns\nFor the fiscal year ending March 2027, continued revenue and profit growth is anticipated, with ongoing growth expected across all segments. The dividend is planned at \u00a522.00 at year-end (YoY +\u00a51), representing a payout ratio of 30.3%. Additionally, a share buyback program has been decided with an acquisition limit of 20 million shares, a total acquisition amount cap of \u00a520 billion, and an acquisition period from May 2, 2026 to April 30, 2027. This aims to improve capital efficiency and maximize shareholder value.","jir_financial_highlights":"Revenue: \u00a5351,363 million (YoY +23.3%)\nOperating Income: \u00a573,547 million (YoY +16.8%)\nProfit Before Tax: \u00a576,276 million (YoY +17.7%)\nNet Income: \u00a554,046 million (YoY +21.9%)\nNet Income Attributable to Owners of Parent: \u00a549,100 million (YoY +21.3%)\nBasic Earnings Per Share: \u00a572.53 (YoY +12.5%)\nTotal Assets: \u00a5637,396 million (YoY +\u00a555,654 million)\nTotal Equity: \u00a5446,648 million (YoY +\u00a533,849 million)\nTreasury Stock (at period-end): 11,695,137 shares (YoY increase (45,271 shares \u2192 11,695,137 shares))\nAnnual Dividend (at period-end): \u00a522.00 (YoY +\u00a51)","jir_category":"","jir_hashtags":"#M3Inc, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Revenue: \u00a5351,363 million (YoY +23.3%)\nOperating Income: \u00a573,547 million (YoY +16.8%)\nNet Income Attributable to Owners of Parent: \u00a549,100 million (YoY +21.3%)","jir_meta_title":"[M3] FY March 2026 Financial Results | Revenue \u00a5351.3 Billion (YoY +23.3%)","jir_meta_description":"M3, Inc.'s financial summary for fiscal year ending March 2026. Revenue of \u00a5351,363 million (YoY +23.3%), operating income of \u00a573,547 million (YoY +16.8%), and net income attributable to owners of parent of \u00a549,100 million (YoY +21.3%) achieved growth. Share buyback program also announced.","jir_og_title":"[M3] FY March 2026 Financial Results | Revenue \u00a5351.3 Billion (YoY +23.3%)","jir_og_description":"M3, Inc. achieved revenue and profit growth for fiscal year ending March 2026 and announced a share buyback program.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Revenue Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year Ended March 2025\\\",\\\"Fiscal Year Ended March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[284900,351363],\\\"backgroundColor\\\":\\\"#4e79a7\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Operating Income Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year Ended March 2025\\\",\\\"Fiscal Year Ended March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[62971,73547],\\\"backgroundColor\\\":\\\"#f28e2b\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"net_income_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year Ended March 2025\\\",\\\"Fiscal Year Ended March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income Attributable to Owners of Parent\\\",\\\"data\\\":[40484,49100],\\\"backgroundColor\\\":\\\"#e15759\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown (Fiscal Year Ending March 2026, Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Medical Platform\\\",\\\"Evidence Solutions\\\",\\\"Career Solutions\\\",\\\"Site Solutions\\\",\\\"Patient Solutions\\\",\\\"Overseas\\\",\\\"Other Emerging Businesses\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[107830,24521,22799,54353,56877,86921,2230],\\\"backgroundColor\\\":[\\\"#4e79a7\\\",\\\"#f28e2b\\\",\\\"#e15759\\\",\\\"#76b7b2\\\",\\\"#59a14f\\\",\\\"#edc949\\\",\\\"#af7aa1\\\"]}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_profit_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Profit Breakdown (Fiscal Year Ending March 2026, Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Medical Platform\\\",\\\"Evidence Solutions\\\",\\\"Career Solutions\\\",\\\"Site Solutions\\\",\\\"Patient Solutions\\\",\\\"Overseas\\\",\\\"Other Emerging Businesses\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Segment Profit\\\",\\\"data\\\":[35918,5120,5925,5766,2686,14898,4878],\\\"backgroundColor\\\":[\\\"#4e79a7\\\",\\\"#f28e2b\\\",\\\"#e15759\\\",\\\"#76b7b2\\\",\\\"#59a14f\\\",\\\"#edc949\\\",\\\"#af7aa1\\\"]}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":7464,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-44745","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n